- Home
- VIPS vs AXSM Comparison
VIPS vs AXSM Comparison
Compare VIPS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIPS | AXSM |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 9.0B |
| IPO Year | 2012 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VIPS | AXSM |
|---|---|---|
| Price | $17.32 | $163.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 18 |
| Target Price | $19.83 | ★ $208.11 |
| AVG Volume (30 Days) | ★ 1.5M | 522.1K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.57 | $61.00 |
| Revenue Next Year | $2.31 | $54.38 |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.14 | $86.99 |
| 52 Week High | $21.08 | $191.50 |
Technical Indicators
Market Signals| Indicator | VIPS | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 46.33 | 32.34 |
| Support Level | $16.83 | $148.14 |
| Resistance Level | $17.79 | $191.13 |
| Average True Range (ATR) | 0.59 | 5.61 |
| MACD | 0.06 | -3.23 |
| Stochastic Oscillator | 34.71 | 12.96 |
Price Performance
Historical ComparisonAbout VIPS Vipshop Holdings Limited
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners . As of March 31, 2025, Eric Ya Shen, chairman and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds an 12.5% interest.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.